XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Cash and Marketable Securities (Tables)
3 Months Ended
Mar. 31, 2021
Cash and Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
A reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):
March 31, 2021December 31, 2020March 31, 2020December 31, 2019
Cash and cash equivalents$309,324 $134,669 $32,191 $38,223 
Restricted cash269 270 242 256 
Total cash, cash equivalents, and restricted cash at the end of the period$309,593 $134,939 $32,433 $38,479 
Debt Securities, Held-to-maturity
The amortized cost, gross unrealized holding losses, and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the table below (in thousands):

March 31, 2021
Amortized CostUnrealized Holding LossesFair Value
Short-term marketable securities:
Corporate debt securities$64,963 $(66)$64,897 
Total short-term marketable securities$64,963 $(66)$64,897 

December 31, 2020
Amortized CostUnrealized Holding LossesFair Value
Short-term marketable securities:
Corporate debt securities$90,034 $(136)$89,898 
Total short-term marketable securities$90,034 $(136)$89,898